Spontaneous b2-Adrenergic Signaling Fails To Modulate L-Type Ca21 Current in Mouse Ventricular Myocytes
YING-YING ZHOU,HEPING CHENG,LONG-SHENG SONG,DINGJI WANG,EDWARD G. LAKATTA,RUI-PING XIAO
1999-01-01
Molecular Pharmacology
Abstract:A receptor can be activated either by specific ligand-directed changes in conformation or by intrinsic, spontaneous confor- mational change. In the b2-adrenergic receptor (AR) overex- pression transgenic (TG4) murine heart, spontaneously acti- vated b2AR (b2-R*) in the absence of ligands has been evidenced by elevated basal adenylyl cyclase activity and car- diac function. In the present study, we determined whether the signaling mediated by b2-R* differs from that of a ligand-elicited b2AR activation (b2-LR*). In ventricular myocytes from TG4 mice, the properties of L-type Ca21 current (ICa), a major effec- tor of b2-LR* signaling, was unaltered, despite a 2.5-fold in- crease in the basal cAMP level and a 1.9-fold increase in baseline contraction amplitude as compared with that of wild- type (WT) cells. Although the contractile response to b2-R* in TG4 cells was abolished by a b2AR inverse agonist, ICI118,551 (5 3 1027 M), or an inhibitory cAMP analog, Rp-CPT-cAMPS (1024 M), no change was detected in the simultaneously re- corded ICa. These results suggest that the increase in basal cAMP due to b2-R*, while increasing contraction amplitude, does not affect ICa characteristics. In contrast, the b2AR ago- nist, zinterol elicited a substantial augmentation of ICa in both TG4 and WT cells (pertussis toxin-treated), indicating that L- type Ca21 channel in these cells can respond to ligand-directed signaling. Furthermore, forskolin, an adenylyl cyclase activator, elicited similar dose-dependent increase in ICa amplitude in WT and TG4 cells, suggesting that the sensitivity of L-type Ca21 channel to cAMP-dependent modulation remains intact in TG4 cells. Thus, we conclude that b2-R* bypasses ICa to modulate contraction, and that b2-LR* and b2-R* exhibit different intra- cellular signaling and target protein specificity.